Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02394886 | Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers | PHASE1 | COMPLETED | 5 | — | — | Nov 1, 2014 | Jul 1, 2015 | Oct 16, 2015 | 1 | South Korea |
| Arm | Type | Description |
|---|---|---|
| ALLO-ASC-DFU | EXPERIMENTAL | ALLO-ASC-DFU treatment with conventional care |
| Name | Type | Description |
|---|---|---|
| ALLO-ASC-DFU | BIOLOGICAL | - |
Inclusion Criteria: 1. Subject is between 18 and 80 years of age. 2. Subject is diagnosed with Type I or Type II diabetes. 3. Subjects who have a wound defined as diabetic foot ulcer presence for more than 4 weeks, but not present for more than 54 weeks at the screening visit. 4. Foot ulcer located...